Clinical Trials
5 trialsNCT06214793 2026-06-05
Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC)
Case Comprehensive Cancer Center
Phase 2 Suspended
NCT07067138 2026-06-04
A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)
National Institutes of Health Clinical Center (CC)
Phase NA Suspended
NCT06130826 2026-06-03
Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer
City of Hope Medical Center
Phase 1 Suspended
NCT05751668 2026-06-02
Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II)
Alliance for Clinical Trials in Oncology
Phase 2 Suspended
NCT07426952 2026-05-19
WeCan-Rural
Duke University
Phase NA Suspended